China US Pharmacopeia USP Standard Hydroxypropyl Betadex Manufacturers, Suppliers, Factory

As the Chinese New Year marks a new beginning, DELI Biochemical continued to deliver reliable cyclodextrin solutions through stable operations, consistent quality, and a shared commitment to long-term global partnerships.

Xi’an Deli Biochemical Industry Co., Ltd. has officially announced the expansion of its active pharmaceutical ingredient (API) and excipient portfolio with the addition of Glucosamine Sulfate Sodium Chloride (CAS 1296149-13-7). Backed by over 26 years of specialized manufacturing experience, the company aims to provide high-purity ingredients, full technical documentation, and scalable global supply support for joint health formulations and pharmaceutical development. Building on its established leadership in cyclodextrin derivatives—such as Hydroxypropyl Betadex (HPBCD) and Sulfobutyl Ether Beta Cyclodextrin Sodium (SBECD)—Xi’an Deli’s latest release reinforces its strategy to deliver diversified, high-quality solutions for pharmaceutical manufacturers and partners across Europe, Asia, and global markets.

Cyclodextrin inclusion technology has become an essential tool in modern drug formulation. Among the most widely used derivatives, Hydroxypropyl Betadex (HPBCD) and Sulfobutyl Ether Beta-Cyclodextrin Sodium (SBECD) play a critical role in improving solubility, stability, and overall drug performance.

What is Sulfobutyl ether beta-cyclodextrin (SEβCD)? ulfobutyl ether beta-cyclodextrin sodium (SBECD) has been used in several medications.